STOCK TITAN

Absci Corp (ABSI) awards two major stock option grants to its CMO

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Absci Corp reported that its CMO and Head of R&D, Ransi Mudalinayake, received two grants of employee stock options. One grant covers 383,000 options with a $7.93 exercise price expiring on August 2, 2036, and another covers 650,000 options at $2.57 expiring on March 2, 2036. For each grant, 25% of the shares vest on the first anniversary of the grant date, with the remaining shares vesting in 36 approximately equal monthly installments, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Somaratne Ransi Mudalinayake
Role CMO, Head of R&D
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) F1 383,000 $0.00 $0.00
Grant/Award Stock Option (right to buy) F1 650,000 $0.00 $0.00
Holdings After Transaction: Stock Option (right to buy) — 1,033,000 shares (Direct)
Footnotes (1)
  1. F1. The shares subject to the option vest over four years, with 25% of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in 36 approximately equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Options granted (strike $7.93) 383,000 shares Stock option grant to CMO and Head of R&D with $7.93 exercise price
Options granted (strike $2.57) 650,000 shares Stock option grant to CMO and Head of R&D with $2.57 exercise price
Exercise price (first grant) $7.93 per share Conversion or exercise price for 383,000-share stock option grant
Exercise price (second grant) $2.57 per share Conversion or exercise price for 650,000-share stock option grant
Expiration date (383,000 options) August 2, 2036 Expiration date for 383,000-share stock option grant
Expiration date (650,000 options) March 2, 2036 Expiration date for 650,000-share stock option grant
Initial vesting cliff 25% after one year Portion of each option grant vesting on first anniversary of grant date
Subsequent vesting installments 36 monthly installments Remaining shares vest in 36 approximately equal monthly installments
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion or exercise price of $7.9300 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration date: 2036-08-02"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"shares subject to the option vest over four years, with 25% of the shares vesting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider activity did Absci Corp (ABSI) disclose for Ransi Mudalinayake?

Absci Corp disclosed that CMO and Head of R&D Ransi Mudalinayake received two grants of employee stock options, covering 383,000 and 650,000 underlying shares, with exercise prices of $7.93 and $2.57, respectively, vesting over four years.

How many stock options were granted on Absci Corp (ABSI) Form 4 at a $7.93 exercise price?

The filing reports a grant of 383,000 stock options with an exercise price of $7.93 per share. These options relate to Absci Corp common stock and are scheduled to expire on August 2, 2036, subject to the stated vesting conditions and continued service.

What are the terms of the 650,000 stock options reported by Absci Corp (ABSI)?

One reported grant consists of 650,000 stock options with an exercise price of $2.57 per share. These options relate to common stock, expire on March 2, 2036, and vest over four years using the same 25%-then-monthly installment schedule described in the footnote.

What vesting schedule applies to the new Absci Corp (ABSI) stock option grants?

Both option grants vest over four years. 25% of the shares vest on the first anniversary of the grant date, and the remaining shares vest in 36 approximately equal monthly installments thereafter, conditioned on the reporting person’s continuous service to Absci Corp.

When do the stock options granted to the Absci Corp (ABSI) CMO expire?

The 383,000-share option grant at $7.93 expires on August 2, 2036, and the 650,000-share grant at $2.57 expires on March 2, 2036. Both are stock options to purchase Absci Corp common stock, subject to vesting.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Somaratne Ransi Mudalinayake

(Last)(First)(Middle)
18105 SE MILL PLAIN BLVD

(Street)
VANCOUVER WASHINGTON 98683

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CMO, Head of R&D
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$2.5703/03/2026A650,000 (1)03/02/2036Common Stock650,000$0650,000D
Stock Option (right to buy)$7.9308/03/2026A383,000 (1)08/02/2036Common Stock383,000$0383,000D
Explanation of Responses:
1. The shares subject to the option vest over four years, with 25% of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in 36 approximately equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Remarks:
/s/ Shelby Walker08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)